Position in ROIV
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$78,749,472
+$36,199,226 QoQ
Shares Held
2,225,190
+44.9% QoQ
Ownership
0.308%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#46
of 489 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ROIV Over Time
Shares Held
Position Value (USD)
Derivatives in ROIV
reported options exposure · as of Jun 30, 2026CallValue
$955,530
CallShares
27,000
PutValue
$955,530
PutShares
27,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026CITIGROUP INC holds $2,091,289,244 across 384 Biotechnology names. ROIV ranks #4 (3.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
706,968 | $351,172,214 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
346,637 | $216,142,034 | |
| 3 | MRNA |
Moderna, Inc.
|
2,165,414 | $151,643,941 | |
| 4 | ROIV |
Roivant Sciences Ltd.
This page
|
2,225,190 | $78,749,472 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
227,786 | $68,570,419 | |
| 6 | INCY |
Incyte Corp
|
586,431 | $66,477,817 | |
| 7 | BBIO |
BridgeBio Pharma, Inc.
|
864,101 | $64,358,241 | |
| 8 | RVMD |
Revolution Medicines, Inc.
|
247,052 | $46,267,897 |
All Filings in ROIV
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $78,749,472 | 2,225,190 | Shares | Defined | 2026-08-03 | |
| 2026-06-30 | $955,530 | 27,000 | Put | Defined | 2026-08-03 | |
| 2026-06-30 | $955,530 | 27,000 | Call | Defined | 2026-08-03 | |
| 2026-03-31 | $747,900 | 27,000 | Call | Defined | 2026-05-11 | |
| 2026-03-31 | $42,550,246 | 1,536,110 | Shares | Defined | 2026-05-11 | |
| 2026-03-31 | $747,900 | 27,000 | Put | Defined | 2026-05-11 | |
| 2025-12-31 | $4,340,000 | 200,000 | Call | Defined | 2026-02-13 | |
| 2025-12-31 | $37,144,843 | 1,711,744 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $3,026,000 | 200,000 | Call | Defined | 2025-11-10 | |
| 2025-09-30 | $26,623,276 | 1,759,635 | Shares | Defined | 2025-11-10 | |
| 2025-06-30 | $16,755,097 | 1,486,699 | Shares | Defined | 2025-08-11 | |
| 2025-03-31 | $7,268,704 | 720,387 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $7,558,245 | 638,905 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $3,424,679 | 296,766 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $1,596,449 | 151,036 | Shares | Defined | 2024-08-12 | |
| 2024-03-31 | $378,386 | 35,900 | Call | Defined | 2024-05-10 | |
| 2024-03-31 | $8,948,933 | 849,045 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $539,040 | 48,000 | Call | Defined | 2024-02-09 | |
| 2023-12-31 | $4,131,582 | 367,906 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $3,812,713 | 326,431 | Shares | Defined | 2023-12-06 | |
| 2023-06-30 | $2,259,452 | 224,152 | Shares | Defined | 2023-08-10 | |
| 2023-03-31 | $4,520,810 | 612,576 | Shares | Defined | 2023-05-11 | |
| 2022-12-31 | $1,041,544 | 130,356 | Shares | Defined | 2023-02-09 | |
| 2022-09-30 | $36,743 | 11,411 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $85,274 | 20,952 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $28,400 | 5,749 | Shares | Defined | 2022-05-12 | |
| 2021-12-31 | $3,044 | 302 | Shares | Defined | 2022-02-10 | |
| No filing history on record for this holder in this stock. | ||||||